Table 1. Summary of K2P Response to BL-1249a.
background | mutant | EC50 (μM) | n (≥) |
---|---|---|---|
K2P2.1(TREK-1) | 5.5 ± 1.2 | 3 | |
K2P2.1(TREK-1)GGG | 19 ± 1 | 3 | |
K2P2.1(TREK-1)Δ322 | 26 ± 8b | 2 | |
K2P2.1(TREK-1)Δ308 | 35 ± 8b | 2 | |
TREK-1/AAK_T | 7.7 ± 0.6 | 2 | |
TREK-1/AAK M4-C | 19 ± 3 | 3 | |
TREK-1/AAK M3-C | 28 ± 2 | 3 | |
TREK-1/AAK M2-C | 39 ± 9 | 3 | |
TREK-1/TRAAK M2 | 26 ± 8 | 3 | |
F172M | 15 ± 2 | 3 | |
F185L | 27 ± 5 | 3 | |
K2P10.1(TREK-2) | 8.0 ± 0.8 | 3 | |
K2P4.1(TRAAK) | 48 ± 10b | 3 | |
TRAAK/EK-1_T | 23 ± 4 | 2 | |
TRAAK/EK-1 M4-C | 45 ± 2 | 3 | |
TRAAK/EK-1 M3-C | 18 ± 2 | 3 | |
TRAAK/EK-1 M2-C | 28 ± 5 | 3 | |
TRAAK/TREK-1 M2 | 43 ± 11 | 3 | |
M134F | 58 ± 34b | 2 | |
L147F | 27 ± 4 | 3 |
Data derived from at least two independent experiments with each data point averaged from at least three oocytes.
Experiments where complete saturation of the response could not be reached due to BL-1249 solubility limits. For these cases, fits were imposed with an upper boundary of 15 (fold activation, I/I0) to estimate EC50 and error.